Chengye Medical Announces Results of Second Treasury Stock Buyback
NQ Score
77/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Chengye Medical has announced the execution results of its second treasury stock buyback, successfully purchasing 1.5 million shares at an average price of NT$29.32 per share, totaling approximately NT$43.97 million, with a cumulative treasury shareholding ratio reaching 0.77%.
AI Analysis
Frequently Asked Questions
- Q: What was the actual buyback period for Chengye Medical?
- A: The actual buyback period was from May 8, 2025 to July 3, 2025.
- Q: What was the average purchase price per share?
- A: The average price was NT$29.32 per share, below the planned range.
- Q: What percentage of shares does the company now hold as treasury stock?
- A: The company holds 0.77% of its issued shares as treasury stock.